Drug

HLX07 clinical trials

Also written HLX07.

studies test it: 14
open now: 4
in phase 3: 2
first study started: 2016

Keep track of what changes. Save the HLX07 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

14 studies that test it; most in 2022 (5)

Studies that test HLX07, by start year
Year	Studies
2016	1
2018	1
2020	1
2022	5
2023	3
2024	1
2026	2

By phase

A phase 1/2 study counts in both.

Phase 1: 3
Phase 2: 12
Phase 3: 2

What it is tested for

Each study’s main condition, where its own words name it.

Neoplasms: 2
Nasopharyngeal Carcinoma: 1
Squamous Cell Carcinoma of Head and Neck: 1
Rectal Neoplasms: 1
Carcinoma, Adenosquamous: 1
Carcinoma, Squamous Cell: 1
Small Cell Lung Carcinoma: 1
Stomach Neoplasms: 1

Who runs them

Industry 13 · Other 1

Shanghai Henlius Biotech (12) · Henlix, Inc (1) · Wuhan Union Hospital, China (1)

Often tested with

Tested in the same studies.

Serplulimab (6) · Cisplatin (2) · Carboplatin (2) · Gemcitabine (1) · Paclitaxel (1) · Modified FOLFOX6 Regimen (1) · Anti-PD-L1 Antibody-drug Conjugate HLX43 (1) · Fluorouracil (1)

Studies

Open first, then newest update. How each study uses HLX07 is read from its arms, and is right about nine times in ten.

Testing it · 14

Given in every arm · 2 — HLX07 is usual care beside what is tested